Mirtazapine Tablet, Film Coated
Product Images NDC 51079-088

7 FDA label images from Mylan Institutional Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 51079-088). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7f2418f8 F476 4079 835d 1b6b57937c7a 01

7f2418f8 F476 4079 835d 1b6b57937c7a 01
Chemical structure of the active ingredient Mirtazapine, showing its molecular framework with nitrogen-containing rings and a methyl group attached.*
FDA Label Image

Mirtazapine Stuctural Formula (Image 01)

Mirtazapine Stuctural Formula (Image 01)
Mirtazapine Tablets, USP 15 mg film-coated tablets are shown on a product label with the NDC 51079-086-20. The label includes a green and black color scheme, displays the strength '15 mg', and shows the imprint 'M 515' on the tablets. The label indicates a package size of 100 tablets (10 x 10) and lists Mylan Pharmaceuticals Inc. as the manufacturer, with the route of administration as oral.*
FDA Label Image

Mirtazapine 15 mg Tablets Unit Carton Label (Image 02)

Mirtazapine 15 mg Tablets Unit Carton Label (Image 02)
Packaging label for Mirtazapine unit-dose oral film-coated tablets by Mylan Institutional Inc. The label includes safety warnings, usage limits for institutional use, and storage instructions emphasizing light resistance and child safety. It also notes the lot number and expiration window, along with a QR code and Mylan's contact information.*
FDA Label Image

Unit Carton (Image 03)

Unit Carton (Image 03)
Mirtazapine Tablets USP 30 mg film-coated tablets in a box labeled with NDC 51079-087-20, containing 100 tablets (10 x 10). The label shows the manufacturer as Mylan Pharmaceuticals Inc., Morgantown, WV. The box features a blue and white color scheme with dosage strength prominently displayed.*
FDA Label Image

Mirtazapine 30 mg Tablets Unit Carton Label (Image 04)

Mirtazapine 30 mg Tablets Unit Carton Label (Image 04)
Packaging label for Mirtazapine oral film-coated tablets by Mylan Institutional Inc. The label indicates a unit-dose package designed for institutional use, with instructions for storage and light resistance. It includes a lot number and expiration date window, along with a QR code and a barcode section.*
FDA Label Image

Mirtazapine 45 mg Tablets Unit Carton Label (Image 05)

Mirtazapine 45 mg Tablets Unit Carton Label (Image 05)
Mirtazapine 45 mg film-coated tablets label from Mylan Institutional Inc. The label shows the product name, strength (45 mg), dosage form (tablets, USP), and indicates a package size of 100 tablets (10 x 10). It includes storage instructions, manufacturer details, a barcode, and the Mylan logo.*
FDA Label Image

Unit Carton (Image 06)

Unit Carton (Image 06)
Mirtazapine unit-dose packaging label in blue, distributed by Mylan Institutional Inc. The label includes instructions noting the package is not child resistant, for institutional use only, and warns to keep out of reach of children. It also states the container provides light resistance and references a window for lot number and expiration date.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.